Evidence map›Paper›PMID 42786227›Full record

ArticleBone marrow transplantation2026

Endothelial complications after post-transplant cyclophosphamide in pediatric HSCT for non-malignant disorders: infants at highest risk.

Alice Corsia, Benjamin Fournier, Martin Castelle, Jean-Sébastien Diana, Roman Klifa, Charles de Marcellus, Maryline Lévy, Bénédicte Neven, Despina Moshous

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alice CorsiaInstitut Imagine, INSERM UMR1163, Université Paris Cité, Paris, France. alice.corsia@gmail.com.
Benjamin FournierPediatric Immunology, Hematology and Rheumatology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Martin CastellePediatric Immunology, Hematology and Rheumatology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jean-Sébastien DianaAPHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, CIC BT 1416, Laboratoire de Thérapie Cellulaire et Génique, Paris, France.ORCID http://orcid.org/0000-0001-8806-011X
Roman KlifaPediatric and Neonatal Intensive Care Unit, Hôpital Universitaire Pellegrin, Université de Bordeaux, Bordeaux, France.
Charles de MarcellusPediatric Intensive Care Unit, Necker Hospital, Necker University Hospital, Paris, France.
Maryline LévyM3C-Necker, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Université de Paris Cité, Paris, France.
Bénédicte NevenPediatric Immunology, Hematology and Rheumatology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0000-0001-8941-0935
Despina MoshousInstitut Imagine, INSERM UMR1163, Université Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42786227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.